Health Data

Using data that is collected from patient visits is a fairly new area of research, but one that is growing very quickly. Being able to access data that is already available on hand can be very valuable to our research teams.

Related News

Research Projects

  1. The impact of new government childcare accreditation standards on children’s in-care physical activity and sedentary time

    29/03/2022

    Tis study focused on a naturally occurring provincial policy change related to physical activity and ST in childcare centres. Findings suggest the new accreditation standard criterion in Alberta, Canada, regardless of the childcare environment, may not be enough on its own to change these behaviours in toddlers or preschoolers. Also, the new accreditation standard combined with coaching support appeared to have little to no impact on educators’ perceptions related to physical activity and sedentary behaviour.

  2. Problem technology use, academic performance, and school connectedness among adolescents

    18/02/2022

    Excessive use and problem technology use are highly prevalent among secondary school students, and they are associated with lower academic performance and lower levels of school connectedness.

  3. Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis

    14/11/2021

    Establishing this framework has been integral to the development of analytical tools.

  4. Near real-time determination of B. 1.1. 7 in proportion to total SARS-CoV-2 viral load in wastewater using an allele-specific primer extension PCR strategy

    15/10/2021

    Our study demonstrates that this strategy can provide public health units with an additional and much needed tool to rapidly triangulate VOC incidence/prevalence with high sensitivity and lineage specificity.

  5. The role of wastewater testing for SARS-CoV-2 surveillance

    26/08/2021

    These characteristics of SARS-CoV-2 infection, along with the observation that SARSCoV-2 is excreted in stools during all phases of infection, has led to the uptake of wastewater testing to complement SARS-CoV-2 surveillance based on clinical tests and case identification.

  6. Can synthetic data be a proxy for real clinical trial data? A validation study

    16/04/2021

    The high concordance between the analytical results and conclusions from synthetic and real data suggests that synthetic data can be used as a reasonable proxy for real clinical trial datasets.

  7. Identification and inclusion of gender factors in retrospective cohort studies: the GOING-FWD framework

    09/04/2021

    The application of the GOING-FWD multistep approach can help guide investigators to analyse gender and its impact on outcomes in previously collected data.

  8. Evaluating the utility of synthetic COVID-19 case data

    01/03/2021

    A privacy risk assessment on the synthetic data showed that the attribute and membership disclosure risks were low.

  9. Regional differences in access to the outdoors and outdoor play of Canadian children and youth during the COVID-19 outbreak

    18/12/2020

    It is unsurprising that in the provinces that have had the highest number of COVID-19 cases, there have been the most stringent restrictions on access to the outdoors. It is also unsurprising that these same provinces have had the greatest decline in time spent outdoors and in outdoor play among children and youth.

  10. Evaluating Identity Disclosure Risk in Fully Synthetic Health Data: Model Development and Validation

    11/11/2020

    We have presented a comprehensive identity disclosure risk model for fully synthetic data. The results for this synthesis method on 2 datasets demonstrate that synthesis can reduce meaningful identity disclosure risks considerably. The risk model can be applied in the future to evaluate the privacy of fully synthetic data.

  11. Canadian Association of Radiologists White Paper on De-Identification of Medical Imaging: Part 1, General Principles

    03/11/2020

    The application of AI algorithms in radiology requires access to large data sets containing PHI. The CAR AI Ethical and Legal standing committee published Part 2 of this guide to provide a practical approach to de-identification in the context of the current Canadian health care landscape. This article discussed the practical application of protecting patient data in the reality of our current Canadian clinical landscape. The strengths and weaknesses of de-identification approaches were outlined, along with the complexities of protecting patients’ medical imaging data, the possible de-identification software tools available, some common mistakes made by research and development teams, and perspectives on future directions.

  12. Abnormal placental pathological findings and adverse clinical outcomes of oocyte donation

    02/11/2020

    Placental pathology reflecting dysregulated immune processes and vasculopathy is associated with oocyte donation.

  13. Exploring data subsets with vtree

    25/10/2020

    While vtree can be used to explore data, it can also be used to generate study-flow diagrams.

  14. Evaluating the psychometric properties of the parent-rated Strengths and Difficulties Questionnaire in a nationally representative sample of Canadian children and adolescents aged 6 to 17 years

    19/08/2020

    The original five-factor, parent-rated SDQ demonstrates evidence of factorial validity and reliability as a population measure of mental health difficulties among Canadian children and adolescents.

  15. Quantitative analysis of SARS-CoV-2 RNA from wastewater solids in communities with low COVID-19 incidence and prevalence

    19/08/2020

    Can we find COVID-19 markers in the wastewater that will help predict outbreaks?

  16. Risk of Lower Birth Weight and Shorter Gestation in Oocyte Donation Pregnancies Compared With Other Assisted Reproductive Technology Methods: Systematic Review

    04/07/2020

    A high degree of interstudy heterogeneity exists, and the association between OD and infant outcomes remains unclear.

  17. Practical Synthetic Data Generation

    29/05/2020

    Data scientists will learn how synthetic data generation provides a way to make such data broadly available for secondary purposes while addressing many privacy concerns. Analysts will learn the principles and steps for generating synthetic data from real datasets. And business leaders will see how synthetic data can help accelerate time to a product or solution.

  18. Building an Anonymization Pipeline

    30/04/2020

    How can you use data in a way that protects individual privacy but still provides useful and meaningful analytics? With this practical book, data architects and engineers will learn how to establish and integrate secure, repeatable anonymization processes into their data flows and analytics in a sustainable manner.

  19. Racial differences in contribution of prepregnancy obesity and excessive gestational weight gain to large-for-gestational-age neonates

    01/02/2020

    Excessive gestational weight gain contributed more to LGA neonates than prepregnancy obesity in Whites and Asians, while there was no difference between excessive gestational weight gain and prepregnancy obesity in their contributions to the LGA neonates in Blacks. The differences are mostly driven by the differential prevalence of the two risk factors across racial groups.

  20. Barriers and Facilitators of Pediatric Shared Decision-Making: A Systematic Review

    01/01/2019

    Our findings can be used to identify potential pediatric SDM barriers and facilitators, guide context-specific barrier and facilitator assessments, and inform interventions for implementing SDM in pediatric practice.

  21. The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)

    01/11/2018

    We anticipate that increasing use of the RECORD-PE guidelines by researchers and endorsement and adherence by journal editors will improve the standards of reporting of pharmacoepidemiological research undertaken using routinely collected data. This improved transparency will benefit the research community, patient care, and ultimately improve public health.

  22. Increasing Incidence and Prevalence of Pathologic Hemoglobinopathies Among Children in Ontario, Canada from 1991-2013

    01/11/2018

    Through an innovative approach using provincial health administrative, immigration and demographic data, this study identified a rising incidence and prevalence of hemoglobinopathies among Ontario children <18 years of age between April 1, 1991 and March 31, 2013, potentially due to increased immigration rates.

  23. Physical Literacy Knowledge Questionnaire: feasibility, validity, and reliability for Canadian children aged 8 to 12 years

    02/10/2018

    Future studies of alternative item wording and responses are recommended to enhance test-retest reliability.

  24. Canada’s Physical Literacy Consensus Statement: process and outcome

    02/10/2018

    Going forward, the impact of this initiative on the sector, and the more distal goal of increasing habitual physical activity levels, should be assessed.

  25. A Pragmatic Method for Identification of Long-Stay Patients in the PICU

    01/10/2018

    We present a pragmatic method for the retrospective identification of LSPs in the PICU that incorporates unit- and/or patient-specific characteristics. The next steps would be to validate this method using other patient and/or unit characteristics in different PICUs and over time.

  26. Defining and identifying concepts of medication literacy: an international perspective

    18/09/2018

    Future studies should focus on how this definition can be operationalized to support the role that pharmacists and other healthcare providers.

  27. Applying Data Preprocessing Methods to Predict Premature Birth

    18/07/2018

  28. Developing an Automated Clinical Trending Tool for the Neonatal Intensive Care Unit (NICU)

    30/05/2018

  29. Conceptual Critique of Canada’s Physical Literacy Assessment Instruments Also Misses the Mark

    09/06/2017

  30. A unified framework for evaluating the risk of re-identification of text de-identification tools

    01/10/2016

    Our framework attempts to correct for poorly distributed evaluation corpora, accounts for the data release context, and avoids the often optimistic assumptions that are made using the more traditional evaluation approach. It therefore provides a more realistic estimate of the true probability of re-identification.

  31. Anonymising and sharing individual patient data

    01/03/2015

    The expected benefits from sharing individual patient data for health research purposes include: it ensures accountability in results and that reported study results are valid, it allows researchers to build on the work of others more efficiently and to perform individual patient data meta-analyses to summarise evidence, and it decreases the burden on research subjects through the reuse of existing data.

  32. New concepts in the assessment of exercise capacity among children with congenital heart disease: Looking beyond heart function and mortality

    10/02/2015

    Physically active lifestyles are important for the physical and mental health of children with congenital heart defects.

  33. Complex care for kids Ontario: protocol for a mixed-methods randomised controlled trial of a population-level care coordination initiative for children with medical complexity

    Our primary objective is to evaluate the CCKO intervention using a randomised waitlist control design. The waitlist approach involves rolling out an intervention over time, whereby all participants are randomised into two groups (A and B) to receive the intervention at different time points determined at random.

Researchers

  1. Tommy Michel Alain

    Senior Scientist, CHEO Research Institute

    View Profile Email
  2. Erika Bariciak

    Investigator, CHEO Research Institute

    View Profile Email
  3. Nick Barrowman

    Associate Scientist, CHEO Research Institute

    View Profile Email
  4. Melanie Bechard

    Investigator, CHEO Research Institute

    View Profile Email
  5. Natalie Bresee

    Investigator, CHEO Research Institute

    View Profile Email
  6. Jean-Philippe Chaput

    Senior Scientist, CHEO Research Institute

    View Profile Email
  7. Dina El Demellawy

    Investigator, CHEO Research Institute

    View Profile Email
  8. Khaled El Emam

    Senior Scientist, CHEO Research Institute Professor, Faculty of Medicine, University of Ottawa

    View Profile Email
  9. Andrea Evans

    Investigator, CHEO Research Institute

    View Profile Email
  10. Deshayne Fell

    Affiliate Investigator, CHEO Research Institute

    View Profile Email
  11. Jeff Gilchrist

    Associate Scientist, CHEO Research Institute

    View Profile Email
  12. Gary Goldfield

    Senior Scientist, CHEO Research Institute

    View Profile Email
  13. Tyson Graber

    Associate Scientist

    View Profile Email
  14. Robert Klaassen

    Scientist, CHEO Research Institute

    View Profile Email
  15. Margaret Lawson

    Senior Scientist, CHEO Research Institute

    View Profile Email
  16. Patricia Longmuir

    Senior Scientist, CHEO Research Institute

    View Profile Email
  17. Alex MacKenzie

    Senior Scientist, CHEO Research Institute

    View Profile Email
  18. Nathalie Major

    Investigator, CHEO Research Institute

    View Profile Email
  19. Kusum Menon

    Senior Scientist, CHEO Research Institute

    View Profile Email
  20. Nicholas Mitsakakis

    Associate Scientist, CHEO Research Institute

    View Profile Email
  21. Kimmo Murto

    Investigator, CHEO Research Institute

    View Profile Email
  22. Sarah Sawyer

    Investigator, CHEO Research Institute

    View Profile Email
  23. Ewurabena Simpson

    Investigator, CHEO Research Institute

    View Profile Email
  24. Mark S. Tremblay

    Senior Scientist, CHEO Research Institute

    View Profile Email
  25. Private: Régis Vaillancourt

    Senior Scientist, CHEO Research Institute

    View Profile Email
  26. Richard Webster

    Investigator, CHEO Research Institute

    View Profile Email
  27. Nancy Young

    Senior Scientist, CHEO Research Institute

    View Profile Email